US OptionsDetailed Quotes

OLMA241220C12500

Watchlist

0.30
0.000.00%

15min DelayClose Dec 2 16:00 ET

0.00High0.00Low

Olema Pharmaceuticals Stock Discussion

Trytosaveabit

17 hours ago

Update

$Olema Pharmaceuticals (OLMA.US)$ Reuters· 3 mins ago
Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement With Novartis in Frontline Metastatic Breast Cancer as Well as $250 Million Equity Private Placement

Trytosaveabit

Nov 30 10:33

Eyes on! TB on hourly! Plus data release coming could help bring volume to help push this bullish formation!

$Olema Pharmaceuticals (OLMA.US)$ Olema Oncology to Present New Data Combining Palazestrant With Ribociclib at the San Antonio Breast Cancer Symposium
Olema will host an investor conference call at 8:00 a.m. ET on December 10, 2024
Poster Details
Title:A Phase 1b/2 study of palazestrant (OP-1250) in combination with ribociclib, in patients with estrogen receptor-positive, human epidermal gr...

Moomoo AI

Nov 25, 2023 06:49

Although the sale doesn't necessarily signify a negative view on the company's future, absence of insider buying could induce concerns. Other company risks should be considered when investing.

President Sean Bohen Sold A Bunch Of Shares In Olema Pharmaceuticals

Moomoo AI

Oct 17, 2023 06:06

Mr. Garland's expertise in biopharma is predicted to boost late-stage development of Olema's lead product. This could solidify the company's influence in shaping next-gen therapies for women's cancers.

Press Release: Olema Oncology Appoints Oncology Biotech Executive Scott Garland to Board of Directors

Weight-loss drugmakers report strong earnings: Boon or bane?

Trytosaveabit

Oct 12, 2023 06:17

NEWS!

$Olema Pharmaceuticals (OLMA.US)$ Olema Pharmaceuticals Announced New Preclinical Data Regarding The Discovery Of Novel Compounds Targeting KAT6, An Epigenetic Target That Is Dysregulated In Breast And Other Cancers

Rivera

May 17, 2023 09:29

Caming

$Olema Pharmaceuticals (OLMA.US)$

Alvinnnnnnngenius

Feb 22, 2023 08:36

Halt up

$Olema Pharmaceuticals (OLMA.US)$

Moomoo Breakfast US

Aug 10, 2022 07:45

Columns Today's pre-market stock movers: RBLX, TTD, VLD, WYNN and more

Gainers:
In reaction to earnings/guidance:
• $The Trade Desk (TTD.US)$+17%, $Workiva (WK.US)$ +15.3%, $Arlo Technologies (ARLO.US)$ +12%, $Array Technologies (ARRY.US)$ +10.3%, $Everbridge (EVBG.US)$ +9.7%, $Catalyst Pharmaceuticals (CPRX.US)$ +9.4%, $Halozyme Therapeutics (HALO.US)$ +8.7%, $Velo3D (VLD.US)$ +7.6%, $CyberArk (CYBR.US)$ + 6.2%, $Haemonetics (HAE.US)$ +5.8%, $Jackson Financial (JXN.US)$ +5.7% (also increases dividend), $Axon Enterprise (AXON.US)$ +4.8%,...

Moomoo Breakfast US

Jul 21, 2022 07:44

Columns Today's pre-market stock movers: TSLA, T, NOK, UAL and more

Gainers:
In reaction to earnings/guidance:
• $Super Micro Computer (SMCI.US)$ +18%, $Nokia Oyj (NOK.US)$ +7.7%, $Danaher (DHR.US)$ +6.3%, $RLI Corp (RLI.US)$ +5%, $CSX Corp (CSX.US)$ +4.3%, $Las Vegas Sands (LVS.US)$ +4.2%, $Alcoa (AA.US)$ +3.4%(also authorizes new $500 mln share repurchase program)
• $Steel Dynamics (STLD.US)$ +2.8%, $Herc Holdings (HRI.US)$ +2.6%, $Tesla (TSLA.US)$ +2.5%, $Philip Morris International (PM.US)$ +2.5%, $F.N.B. Corp (FNB.US)$ ...

Moomoo Breakfast US

Jun 9, 2022 07:23

Columns Today's pre-market stock movers: NIO, NVAX, TSLA, SIG and more

Gainers:
• $Signet Jewelers (SIG.US)$ +7.6% (In reaction to earnings/guidance)
• $Oxford Industries (OXM.US)$ +6.3% (In reaction to earnings/guidance)
• $BridgeBio Pharma (BBIO.US)$ +5%(to Present Phase 2b Data and Pivotal Phase 3 Study Design of Encaleret in Autosomal Dominant Hypocalcemia Type 1 (ADH1) at the Endocrine Society (ENDO) 2022 Annual Conference)
• $Greif (GEF.US)$ +4.6% (In reaction to earnings/guidance)
• $Olema Pharmaceuticals (OLMA.US)$ +4.3% (an...

No comment yet